Showing results (91-100 of 99) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Oncogene|July 4, 2012
Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivoR B Luwor, B Baradaran, L E Taylor, et al.Brain : a Journal of Neurology|July 30, 2004
MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndromeR P Carne, T J O'Brien, C J Kilpatrick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancerK Clarke, R L Basser, D Maher, et al.Neurobiology of Disease|January 12, 2011
Stargazin and AMPA receptor membrane expression is increased in the somatosensory cortex of Genetic Absence Epilepsy Rats from StrasbourgJ T T Kennard, R Barmanray, S Sampurno, et al.Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics and pharmacodynamics of MX2 hydrochloride in patients with advanced malignant diseaseD J Morgan, J S Hill, K Clarke, et al.Cancer Chemotherapy and Pharmacology|April 2, 1998
Effect of filgrastim on the pharmacokinetics of MX2 hydrochloride in patients with advanced malignant diseaseD J Morgan, J S Hill, K Clarke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrinM A Rosenthal, B Kavar, J S Hill, et al.British Journal of Cancer|July 3, 2008
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugsD M Ashley, C D Riffkin, M M Lovric, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade gliomaK Clarke, R L Basser, C Underhill, et al.Pageof 10